Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. is an Indian listed company in the Healthcare Services industry (Healthcare sector), traded under NSE: LALPATHLAB and BSE: 539524 (ISIN INE600L01024).
It has a market capitalisation of ₹30,900 crore, a last close of ₹1,844 on 2026-10-19, a one-year return of 18.6%.
Valuation: a price-to-earnings ratio of 57.02x, a price-to-book ratio of 12.32x, a dividend yield of 0.9%.
Profitability: return on equity of 21.6%, return on capital employed of 27.6%, an operating margin of 29.0%.
Growth: sales growth of 11.1% a year over three years, net profit growth of 28.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 52.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 30,900 |
| Last close | ₹1,844 |
| P/E (TTM) | 57.02x |
| P/B | 12.32x |
| Dividend yield | 0.9% |
| ROE (FY) | 21.6% |
| ROCE (FY) | 27.6% |
| Operating margin (TTM) | 29.0% |
| Sales growth, 3-year CAGR | 11.1% |
| Profit growth, 3-year CAGR | 28.3% |
| Debt / equity | 0.00x |
| Promoter holding | 52.9% |
| 1-year return | 18.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means